BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 12426033)

  • 1. Low N-acetyl-aspartate and high choline in the anterior cingulum of recently abstinent methamphetamine-dependent subjects: a preliminary proton MRS study. Magnetic resonance spectroscopy.
    Nordahl TE; Salo R; Possin K; Gibson DR; Flynn N; Leamon M; Galloway GP; Pfefferbaum A; Spielman DM; Adalsteinsson E; Sullivan EV
    Psychiatry Res; 2002 Nov; 116(1-2):43-52. PubMed ID: 12426033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methamphetamine users in sustained abstinence: a proton magnetic resonance spectroscopy study.
    Nordahl TE; Salo R; Natsuaki Y; Galloway GP; Waters C; Moore CD; Kile S; Buonocore MH
    Arch Gen Psychiatry; 2005 Apr; 62(4):444-52. PubMed ID: 15809412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (1)H-magnetic resonance spectroscopy ((1)H-MRS) in methamphetamine dependence and methamphetamine induced psychosis.
    Howells FM; Uhlmann A; Temmingh H; Sinclair H; Meintjes E; Wilson D; Stein DJ
    Schizophr Res; 2014 Mar; 153(1-3):122-8. PubMed ID: 24529366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between N-acetyl-aspartate in gray and white matter of abstinent methamphetamine abusers and their history of drug abuse: a proton magnetic resonance spectroscopy study.
    Sung YH; Cho SC; Hwang J; Kim SJ; Kim H; Bae S; Kim N; Chang KH; Daniels M; Renshaw PF; Lyoo IK
    Drug Alcohol Depend; 2007 Apr; 88(1):28-35. PubMed ID: 17084995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of acute and short-term methamphetamine abstinence on brain metabolites: A proton magnetic resonance spectroscopy chemical shift imaging study.
    Burger A; Brooks SJ; Stein DJ; Howells FM
    Drug Alcohol Depend; 2018 Apr; 185():226-237. PubMed ID: 29471227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended findings of brain metabolite normalization in MA-dependent subjects across sustained abstinence: a proton MRS study.
    Salo R; Buonocore MH; Leamon M; Natsuaki Y; Waters C; Moore CD; Galloway GP; Nordahl TE
    Drug Alcohol Depend; 2011 Jan; 113(2-3):133-8. PubMed ID: 20739127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia.
    O'Neill J; Levitt J; Caplan R; Asarnow R; McCracken JT; Toga AW; Alger JR
    Neuroimage; 2004 Apr; 21(4):1781-9. PubMed ID: 15050598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attentional control and brain metabolite levels in methamphetamine abusers.
    Salo R; Nordahl TE; Natsuaki Y; Leamon MH; Galloway GP; Waters C; Moore CD; Buonocore MH
    Biol Psychiatry; 2007 Jun; 61(11):1272-80. PubMed ID: 17097074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of antidepressant treatment on N-acetyl aspartate levels of medial frontal cortex in drug-free depressed patients.
    Gonul AS; Kitis O; Ozan E; Akdeniz F; Eker C; Eker OD; Vahip S
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):120-5. PubMed ID: 16236417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frontal white matter biochemical abnormalities in first-episode, treatment-naive patients with major depressive disorder: a proton magnetic resonance spectroscopy study.
    Wang Y; Jia Y; Xu G; Ling X; Liu S; Huang L
    J Affect Disord; 2012 Feb; 136(3):620-6. PubMed ID: 22129769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities.
    Chang L; Ernst T; Speck O; Grob CS
    Am J Psychiatry; 2005 Feb; 162(2):361-9. PubMed ID: 15677602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Proton magnetic resonance spectroscopy and diffusion tensor imaging study of first-episode patients with positive symptoms of schizophrenia].
    Jia YB; Wang Y; Ling XY; Zhong SM; Huang L
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Mar; 32(3):374-8. PubMed ID: 22445987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced N-acetylaspartate levels in the frontal cortex of 3,4-methylenedioxymethamphetamine (Ecstasy) users: preliminary results.
    Reneman L; Majoie CB; Flick H; den Heeten GJ
    AJNR Am J Neuroradiol; 2002 Feb; 23(2):231-7. PubMed ID: 11847047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton magnetic resonance spectroscopy of the anterior cingulate gyrus, insular cortex and thalamus in schizophrenia associated with idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome).
    Yasukawa R; Miyaoka T; Mizuno S; Inagaki T; Horiguchi J; Oda K; Kitagaki H
    J Psychiatry Neurosci; 2005 Nov; 30(6):416-22. PubMed ID: 16327875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cortical neurochemistry in euthymic patients with bipolar I disorder.
    Scherk H; Backens M; Schneider-Axmann T; Usher J; Kemmer C; Reith W; Falkai P; Gruber O
    World J Biol Psychiatry; 2009; 10(4):285-94. PubMed ID: 19921970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multinuclear magnetic resonance spectroscopy of high-energy phosphate metabolites in human brain following oral supplementation of creatine-monohydrate.
    Lyoo IK; Kong SW; Sung SM; Hirashima F; Parow A; Hennen J; Cohen BM; Renshaw PF
    Psychiatry Res; 2003 Jun; 123(2):87-100. PubMed ID: 12850248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in temporal N-acetylaspartate and creatine (or choline) ratio in temporal lobe epilepsy: does this 1H-magnetic resonance spectroscopy finding mean poor seizure control?
    Mendes-Ribeiro JA; Soares R; Simões-Ribeiro F; Guimarães ML
    J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):518-22. PubMed ID: 9771777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measuring mania metabolites: a longitudinal proton spectroscopy study of hypomania.
    Malhi GS; Ivanovski B; Wen W; Lagopoulos J; Moss K; Sachdev P
    Acta Psychiatr Scand Suppl; 2007; (434):57-66. PubMed ID: 17688464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
    Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton magnetic resonance spectroscopy in subjects at risk for schizophrenia.
    Jessen F; Scherk H; Träber F; Theyson S; Berning J; Tepest R; Falkai P; Schild HH; Maier W; Wagner M; Block W
    Schizophr Res; 2006 Oct; 87(1-3):81-8. PubMed ID: 16842971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.